Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Appl Mater Interfaces ; 13(50): 59820-59833, 2021 Dec 22.
Article in English | MEDLINE | ID: mdl-34875170

ABSTRACT

Metal oxide pseudocapacitors are limited by low electrical and ionic conductivities. The present work integrates defect engineering and architectural design to exhibit, for the first time, intercalation pseudocapacitance in CeO2-x. An engineered chronoamperometric electrochemical deposition is used to synthesize 2D CeO2-x nanoflakes as thin as ∼12 nm. Through simultaneous regulation of intrinsic and extrinsic defect concentrations, charge transfer and charge-discharge kinetics with redox and intercalation capacitances together are optimized, where reduction increases the gravimetric capacitance by 77% to 583 F g-1, exceeding the theoretical capacitance (562 F g-1). Mo ion implantation and reduction processes increase the specific capacitance by 133%, while the capacitance retention increases from 89 to 95%. The role of ion-implanted Mo6+ is critical through its interstitial solid solubility, which is not to alter the energy band diagram but to facilitate the generation of electrons and to establish the midgap states for color centers, which facilitate electron transfer across the band gap, thus enhancing n-type semiconductivity. Critically, density functional theory simulations reveal, for the first time, that the reduction causes the formation of ordered oxygen vacancies that provide an atomic channel for ion intercalation. These channels enable intercalation pseudocapacitance but also increase electrical and ionic conductivities. In addition, the associated increased active site density enhances the redox such that the 10% of the Ce3+ available for redox (surface only) increases to 35% by oxygen vacancy channels. These findings are critical for any oxide system used for energy storage systems, as they offer both architectural design and structural engineering of materials to maximize the capacitance performance by achieving accumulative surface redox and intercalation-based redox reactions during the charge/discharge process.

2.
Biomacromolecules ; 21(11): 4569-4576, 2020 11 09.
Article in English | MEDLINE | ID: mdl-32597638

ABSTRACT

Spontaneous formation of vesicles from the self-assembly of two specific surfactants, one zwitterionic (oleyl amidopropyl betaine, OAPB) and the other anionic (Aerosol-OT, AOT), is explored in water using small-angle scattering techniques. Two factors were found to be critical in the formation of vesicles: surfactant ratio, as AOT concentrations less than equimolar with OAPB result in cylindrical micelles or mixtures of micellar structures, and salt concentration, whereby increasing the amount of NaCl promotes vesicle formation by reducing headgroup repulsions. Small-angle neutron scattering measurements reveal that the vesicles are approximately 30-40 nm in diameter, depending on sample composition. Small-angle X-ray scattering measurements suggest preferential partitioning of OAPB molecules on the vesicle inner layer to support vesicular packing. Heating the vesicles to physiological temperature (37 °C) causes them to collapse into smaller ellipsoidal micelles (2-3 nm), with higher salt concentrations (≥10 mM) inhibiting this transition. These aggregates could serve as responsive carriers for loading or unloading of aqueous cargoes such as drugs and pharmaceuticals, with temperature changes serving as a simple release/uptake mechanism.


Subject(s)
Micelles , Surface-Active Agents , Anions , Betaine , Scattering, Small Angle
3.
Colloids Surf B Biointerfaces ; 182: 110362, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31351271

ABSTRACT

Liposomal formulations have important therapeutic applications in anti-cancer treatments but current formulations suffer from serious side effects, high dosage requirements and prolonged treatment. In this study, PEGylated azide-functionalized liposomes containing drug nanocrystals were investigated with the aim of increasing the drug payload and achieving functionalization for targeted delivery. Liposomes were characterized using cryogenic transmission electron microscopy (cryo-TEM), dynamic light scattering (DLS), small and ultra-small angle neutron scattering (SANS/USANS) and small and wide angle X-ray scattering (SAXS/WAXS). Cryo-TEM experiments revealed the dimensions of the nanocrystal-loaded liposomes and the change of shape from spherical to elongated after the formation of nanocrystals. Results from SANS/USANS experiments confirmed the asymmetric particle shape. SAXS/WAXS experiments confirmed that the crystalline drug only occurred in freeze-thawed samples and correlated with a new unidentified polymorphic form of ciprofloxacin. Using a small molecule dye, dibenzocyclooctyne (DBCO)-cy5, specific conjugation between DBCO groups and surface azide groups on the liposomes was confirmed; this indicates the promise of this system for tumour-targeted delivery.


Subject(s)
Anti-Bacterial Agents/chemistry , Ciprofloxacin/chemistry , Drug Compounding/methods , Liposomes/chemical synthesis , Nanoparticles/chemistry , Polyethylene Glycols/chemistry , Azides/chemistry , Cyclooctanes/chemistry , Drug Delivery Systems/methods , Fluorescent Dyes/chemistry , Freezing , Humans , Nanoparticles/ultrastructure , Phosphatidylethanolamines/chemistry , Surface Properties
4.
J Colloid Interface Sci ; 534: 518-532, 2019 Jan 15.
Article in English | MEDLINE | ID: mdl-30253353

ABSTRACT

A model zwitterionic surfactant, oleyl amidopropyl betaine (OAPB), that spontaneously forms viscoelastic wormlike micelles in aqueous solution is mixed with a variety of structurally diverse organic additives. By systematically varying the nature of these additives, insight into the effects of their aromaticity and polarity on the bulk assembly and fluid behaviour of these micelles is gained by the complementary use of small-angle neutron scattering and viscosity measurements. Inclusion of non-polar additives causes the wormlike aggregates to transition into microemulsions above a critical additive concentration; the precise partitioning within the micelle is determined using contrast variation. Alternatively, polar additives do not appear to cause evolution from the wormlike structure, but instead influence the fluid rheology, with some serving to significantly increase viscosity above that of the pure surfactant solution. Addition of these molecules is accompanied by an increase in fluid viscosity when the oxygenated group of the additive is resonance stabilised or acidic. This effect is thought to be a result of surfactant-additive synergism, in which charge screening of the surfactant head-groups causes stronger attractions between molecules, increasing the scission energy of the micelles (i.e. reducing their ability to break apart and reform). Further doping of acidic additives past a critical concentration causes phase separation of the wormlike mixtures. According to ultra-small-angle neutron scattering measurements, the incorporation of all additives (polar or non-polar, aromatic or non-aromatic) results in the formation of 'branched' wormlike networks. These findings emphasise the significant impact of impurities or additives on the properties of aqueous wormlike micellar systems formed by zwitterionic surfactants, and could also inform selection of solutes for controlling fluid rheology.

5.
Org Biomol Chem ; 14(39): 9388-9405, 2016 Oct 04.
Article in English | MEDLINE | ID: mdl-27714195

ABSTRACT

The sigma-1 receptor (S1R) has attracted a great deal of attention as a prospective drug target due to its involvement in numerous neurological disorders and, more recently, for its therapeutic potential in neuropathic pain. As there was no crystal structure of this membrane-bound protein reported until 2016, ligand generation was driven by pharmacophore refinements to the general model suggested by Glennon and co-workers. The generalised S1R pharmacophore comprises a central region where a basic amino group is preferred, flanked by two hydrophobic groups. Guided by this pharmacophore, S1R ligands containing piperazines, piperazinones, and ethylenediamines have been developed. In the current work, we systematically deconstructed the piperazine core of a prototypic piperazine S1R ligand (vide infra) developed in our laboratories. Although we did not improve the affinity at the S1R compared to the lead, we identified several features important for affinity and selectivity. These included at least one basic nitrogen atom, conformational flexibility and, for S1R, a secondary or tertiary amine group proximal to the anisole. Furthermore, S2R selectivity can be tailored with functional group modifications of the N-atom proximal to the anisole.


Subject(s)
Diamines/chemistry , Diamines/metabolism , Receptors, sigma/metabolism , Animals , Binding Sites , Brain/drug effects , Brain/metabolism , Drug Evaluation, Preclinical/methods , Ethylenediamines/chemistry , Guinea Pigs , Ligands , Piperazine , Piperazines/chemistry , Radioligand Assay , Rats , Receptors, sigma/chemistry , Structure-Activity Relationship , Sigma-1 Receptor
6.
Curr Top Med Chem ; 11(5): 521-42, 2011.
Article in English | MEDLINE | ID: mdl-21189131

ABSTRACT

With an ageing baby-boomer population in the Western World, cancer is becoming a significant cause of death. The prevalence of cancer and all associated costs, both in human and financial terms, drives the search for new therapeutic drugs and treatments. Platinum anticancer agents, such as cisplatin have been highly successful but there are several disadvantages associated with their use. What is need are new compounds with different mechanisms of action and resistance profiles. What needs to be recognised is that there are many other metal in the periodic table with therapeutic potential. Here we have highlighted metal complexes with activity and have illustrate the different approaches to the design of anticancer complexes.


Subject(s)
Antineoplastic Agents/pharmacology , Neoplasms/drug therapy , Organometallic Compounds/pharmacology , Transition Elements/chemistry , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , DNA, Neoplasm/chemical synthesis , DNA, Neoplasm/chemistry , DNA, Neoplasm/drug effects , Drug Screening Assays, Antitumor , Humans , Neoplasms/diagnosis , Neoplasms/pathology , Organometallic Compounds/chemistry
7.
Chemistry ; 16(24): 7064-77, 2010 Jun 25.
Article in English | MEDLINE | ID: mdl-20533453

ABSTRACT

The approved platinum(II)-based anticancer agents cisplatin, carboplatin and oxaliplatin are widely utilised in the clinic, although with numerous disadvantages. With the aim of circumventing unwanted side-effects, a great deal of research is being conducted in the areas of cancer-specific targeting, drug administration and drug delivery. The targeting of platinum complexes to cancerous tissues can be achieved by the attachment of small molecules with biological significance. In addition, the administration of platinum complexes in the form of platinum(IV) allows for intracellular reduction to release the active form of the drug, cisplatin. Drug delivery includes such technologies as liposomes, dendrimers, polymers and nanotubes, with all showing promise for the delivery of platinum compounds. In this paper we highlight some of the recent advances in the field of platinum chemotherapeutics, with a focus on the technologies that attempt to utilise the cytotoxic nature of cisplatin, whilst improving drug targeting to reduce side-effects.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Dendrimers/chemistry , Organoplatinum Compounds/pharmacology , Organoplatinum Compounds/therapeutic use , Serum Albumin/chemistry , Carboplatin/chemistry , Carboplatin/therapeutic use , Cisplatin/chemistry , Drug Delivery Systems , Humans , Molecular Structure , Nanotubes, Carbon/chemistry , Neoplasms/drug therapy , Organoplatinum Compounds/chemistry , Prodrugs/chemistry , Prodrugs/therapeutic use , Serum Albumin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...